戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              HIF-1alpha (hypoxia-inducible factor 1alpha) directly bo
2                                              HIF-1alpha activation in MCT-RVfib reflected increased D
3                                              HIF-1alpha activation lowered surface BCR, CD19 and B ce
4                                              HIF-1alpha and HIF-2alpha have common as well as distinc
5                                              HIF-1alpha deletion had no effect on the increase in nor
6                                              HIF-1alpha depletion from CD4(+) T cells reduced frequen
7                                              HIF-1alpha is detectable in GCF and saliva of periodonta
8                                              HIF-1alpha mediated changes in gene expression in CNS re
9                                              HIF-1alpha overexpression significantly increased CSC su
10                                              HIF-1alpha positively regulates Th17 differentiation, a
11                                              HIF-1alpha stabilization was detected in peripheral bloo
12                                              HIF-1alpha total amount in GCF were also higher in perio
13                                              HIF-1alpha was stabilised in PC12 cells by all the PHD i
14                                              HIF-1alpha, and its downstream proteins, glucose transpo
15                                              HIF-1alpha-mutated MDSCs significantly secrete various a
16 .IMPORTANCE Hypoxia inducible factor 1alpha (HIF-1alpha) and HIF-2alpha are transcription factors whi
17 es activate hypoxia-inducible factor 1alpha (HIF-1alpha) and this transcription factor can drive VEGF
18 nesis, with hypoxia-inducible factor 1alpha (HIF-1alpha) being a major contributor.
19 tion factor hypoxia-inducible factor 1alpha (HIF-1alpha) binds a hypoxia response element (HRE) locat
20 esized that hypoxia inducible factor 1alpha (HIF-1alpha) in CNS respiratory centres is necessary for
21             Hypoxia-inducible factor 1alpha (HIF-1alpha) is a major determinant in the enhanced funct
22         The hypoxia-inducible factor 1alpha (HIF-1alpha) is critically involved in tissue regeneratio
23             Hypoxia-inducible factor 1alpha (HIF-1alpha), a principal regulator of innate immunity to
24 esized that hypoxia inducible factor 1alpha (HIF-1alpha), an O(2) -sensitive transcription factor, is
25 ominantly a hypoxia-inducible factor 1alpha (HIF-1alpha)-dependent gene under hypoxia.
26 pression of hypoxia-inducible factor 1alpha (HIF-1alpha).
27 ker protein hypoxia-inducible factor-1alpha (HIF-1alpha) after 3 h of exposure to static hypoxia.
28 report that hypoxia-inducible factor-1alpha (HIF-1alpha) is crucial for the enhancement of placental
29         The hypoxia-inducible factor-1alpha (HIF-1alpha) promotes an adaptive transcriptional respons
30 e show that hypoxia-inducible factor-1alpha (HIF-1alpha), expressed in endothelial cells (ECs), is th
31 , activated hypoxia-inducible factor-1alpha (HIF-1alpha), proliferation and upregulation prolyl hydro
32 iation with hypoxia-inducible factor-1alpha (HIF-1alpha), vascular endothelial growth factor (VEGF-A)
33 seeded with hypoxia inducible factor-1alpha (HIF-1alpha)-mutated muscle-derived stem cells (MDSCs) to
34 mRNAs (e.g. hypoxia-inducible factor 1alpha [HIF-1alpha], fibroblast growth factor 9 [FGF-9], and p53
35 d with elevated levels of acetyl-HIF-1alpha, HIF-1alpha, and aromatase in breast tissue of obese comp
36 (2)-mediated increases in acetyl-HIF-1alpha, HIF-1alpha, and aromatase.
37 teroids suggests that activation of the IL-4-HIF-1alpha-IL-13 axis might play a role in the developme
38 t of the interleukin 6 cytokine family, as a HIF-1alpha target gene, which directly inhibits the TGF-
39 KM2 up-regulates BMSC CXCL12 production in a HIF-1alpha-dependent fashion, which subsequently enhance
40 of HIF-1alpha via short interfering RNA or a HIF-1alpha inhibitor decreased their production.
41 s mitochondrial dynamics in cancer through a HIF-1alpha-regulated pseudohypoxic state.
42 ted SIRT1 levels, leading to elevated acetyl-HIF-1alpha and HIF-1alpha levels and enhanced aromatase
43  blocked PGE(2)-mediated increases in acetyl-HIF-1alpha, HIF-1alpha, and aromatase.
44 re associated with elevated levels of acetyl-HIF-1alpha, HIF-1alpha, and aromatase in breast tissue o
45 P-associated factor (PCAF), which acetylates HIF-1alpha, blocked PGE(2)-mediated increases in acetyl-
46 -145, that nuclear S1P, histone acetylation, HIF-1alpha expression, and TNBC tumor growth were all re
47 h hypoxic and pseudohypoxic stimuli activate HIF-1alpha and its target genes in ATM during diet-induc
48            FCF has also been shown to affect HIF-1alpha and HER2, which are both known to play a cruc
49     Furthermore, both inhibition of PI3K/AKT/HIF-1alpha and attenuation of glycolysis significantly b
50 ll death in bladder cancer cells by PI3K/AKT/HIF-1alpha-mediated glycolysis promotion.
51  parallel, hypoxia inducible factor-1 alpha (HIF-1alpha) activates RASSF1A transcription via HIF-bind
52 d increase hypoxia-inducible factor-1 alpha (HIF-1alpha) activation, thereby promoting neovasculariza
53 ediated by hypoxia-inducible factor 1 alpha (HIF-1alpha) and recombination signal-binding protein for
54  levels of hypoxia-inducible factor-1 alpha (HIF-1alpha) and the synthesis of extracellular matrix pr
55 ected with hypoxia-inducible factor-1 alpha (HIF-1alpha) by using electroporation method, specificall
56            Hypoxia-inducible factor-1 alpha (HIF-1alpha) is expressed as an adaptive response to hypo
57 cts of the hypoxia-inducible factor-1 alpha (HIF-1alpha) transcription factor on osteoclast formation
58 ies (ROS), hypoxia inducible factor 1 alpha (HIF-1alpha), and its target genes in the islets were exa
59 ncrease of hypoxia inducible factor 1 alpha (HIF-1alpha), but a reduction of HIF-2alpha protein expre
60  involving hypoxia inducible factor-1 alpha (HIF-1alpha), vascular endothelial growth factor (VEGF) a
61 duction of hypoxia-inducible factor 1 alpha (HIF-1alpha).
62 ization of Hypoxia Inducible Factor-1 alpha (HIF-1alpha).
63 of hypoxia-inducible factor 1 subunit alpha (HIF-1alpha) and phagosomal recruitment of mammalian targ
64 e limitations of the present study, although HIF-1alpha seems to possess a potential diagnostic value
65 genome expression analysis, we found that an HIF-1alpha transcriptional footprint is preferentially u
66       Exposure of infected macrophages to an HIF-1alpha stabilizer significantly reduced recovery of
67  to test the involvement of microRNA-126 and HIF-1alpha in a model of replicative endothelial senesce
68 rd to the interplay between microRNA-126 and HIF-1alpha, transfection with a microRNA-126 inhibitor d
69 s, leading to elevated acetyl-HIF-1alpha and HIF-1alpha levels and enhanced aromatase gene transcript
70 n of BMP4 (bone morphogenetic protein 4) and HIF-1alpha (hypoxia-inducible factor 1alpha), blocking t
71              Levels of ADAMTS-1, VEGF-A, and HIF-1alpha in GCF and serum were quantified by enzyme-li
72 nt correlation between ADAMTS-1, VEGF-A, and HIF-1alpha levels in the GCF and clinical periodontal pa
73        Moreover, suppression of PI3K/AKT and HIF-1alpha attenuated Vitamin K2-increased glucose consu
74 cating that Vitamin K2 promotes PI3K/AKT and HIF-1alpha-mediated glycolysis in bladder cancer cells.
75 GCF and salivary samples were collected; and HIF-1alpha, VEGF, and TNF-alpha levels were measured by
76 31, VEGF, VEGF receptor II, phosphor-ERK and HIF-1alpha.
77 y, our data identify enhanced glycolysis and HIF-1alpha activation as drivers of low-grade inflammati
78 atty acid palmitate increased glycolysis and HIF-1alpha expression, which culminated in IL-1beta indu
79 ation of HIF-1 and suggests that hypoxia and HIF-1alpha stabilization can be uncoupled in cancer.
80 d lysosomal associated protein 2 (LAMP2) and HIF-1alpha levels and modified cytokine production.
81                                   SphK2, and HIF-1alpha expression levels are elevated in metastatic
82 1 gene promoter, inducing Zta synthesis, and HIF-1alpha-stabilizing drugs can induce EBV reactivation
83 antly, DFO induced binding of p53 as well as HIF-1alpha to Zp in chromatin immunoprecipitation (ChIP)
84 antly inhibited the expression of astrocytic HIF-1alpha, and the downstream genes GLUT-1, EPO, and VE
85                                         Both HIF-1alpha and HIF-2alpha are required for the clear cel
86     Relevant to this, binding sites for both HIF-1alpha and ERalpha overlap in SNAT2's cis-regulatory
87       The TiPARP nuclear bodies recruit both HIF-1alpha and an E3 ubiquitin ligase HUWE1, which promo
88 S neurons (CNS-HIF-1alpha(-/-) ) by breeding HIF-1alpha floxed mice with mice expressing Cre-recombin
89 increased lung metastatic tumours, caused by HIF-1alpha-dependent endothelial cell death and increase
90 e that induction of BZLF1 gene expression by HIF-1alpha requires phosphorylated, wild-type p53 as a c
91  of which are at least partially mediated by HIF-1alpha.
92 cles released by these cells failed to carry HIF-1alpha.
93  bFGF-p38 MAP kinase signaling, beta-catenin-HIF-1alpha expression, and the nuclear size.
94                      After sepsis challenge, HIF-1alpha but not HIF-2alpha expression was rapidly ind
95 th WT and MT p53 proteins bind and chaperone HIF-1alpha to stabilize its binding at its downstream DN
96                     In normal circumstances, HIF-1alpha protein turnover is rapid, and hyperglycemia
97 k, ventilation in hypoxia was blunted in CNS-HIF-1alpha(-/-) and significantly decreased in NTS-HIF-1
98 s constitutively deleted in CNS neurons (CNS-HIF-1alpha(-/-) ) by breeding HIF-1alpha floxed mice wit
99 n of RBPJkappa with DNA sequences containing HIF-1alpha-binding sites.
100                                 In contrast, HIF-1alpha (fl/fl) /LysMcre mice had a significantly sma
101 eries from AD-HIES patients showed decreased HIF-1alpha expression and revealed abnormal organization
102                   MCT-RVfib manifest a DNMT1-HIF-1alpha-PDK-mediated, chamber-specific, metabolic mem
103  with a microRNA-126 inhibitor downregulated HIF-1alpha expression in early passage endothelial cells
104 n, and was attenuated in the setting of dual HIF-1alpha and HIF-2alpha knockdown.
105 er, RNA-seq analysis identified dysregulated HIF-1alpha target genes that are relevant to cell prolif
106 KT/mTOR pathway and its downstream effectors HIF-1alpha and VEGF-A in cell lines, xenografts, and tra
107 deletion of VHL in CD4 T cells would elevate HIF-1alpha and increase Th17 differentiation.
108 nducible factor (HIF) genes, HIF1A (encoding HIF-1alpha) and endothelial PAS domain protein 1 (EPAS1
109  delineate the essential role of endothelial HIF-1alpha in driving the vascular repair program.
110 n LC3-II to the phagosome, whereas enhancing HIF-1alpha reduced phagosomal decoration.
111 Hypoxia-inducible factors (HIFs), especially HIF-1alpha and HIF-2alpha, are key mediators of the adap
112 enescent endothelial cells failed to express HIF-1alpha, and the microvesicles released by these cell
113 ges were also the major cell type expressing HIF-1alpha during infection and that infection-induced V
114 f the hypoxia-inducible transcription factor HIF-1alpha is necessary for chondrocyte survival by unid
115 reby the oxygen-sensing transcription factor HIF-1alpha orchestrated epithelial barrier integrity, se
116 d by the oxygen-sensing transcription factor HIF-1alpha, which is degraded under normoxic conditions
117 d up-regulation of hypoxia-inducible factor (HIF-1alpha), its translocation and binding to the long n
118  via hypoxia-inducible transcription factors HIF-1alpha and HIF-2alpha, regulates TEM function in the
119 inase (AMPK), and hypoxia-inducible factors (HIF-1alpha and HIF-2alpha)-can exert renoprotective effe
120                                       First, HIF-1alpha was constitutively deleted in CNS neurons (CN
121             Our results indicated a role for HIF-1alpha in down-regulating mitochondrial metabolism w
122                                          GCF HIF-1alpha and TNF-alpha total amounts in gingivitis gro
123                                          GCF HIF-1alpha levels in G-AgP reduced at 1 and 3 months pos
124                                          GCF HIF-1alpha, VEGF, and TNF-alpha total amounts were posit
125  At baseline all clinical parameters and GCF HIF-1alpha, VEGF, and TNF-alpha levels were significantl
126 P and CP groups had significantly higher GCF HIF-1alpha, VEGF, and TNF-alpha total amounts than gingi
127 treatment on gingival crevicular fluid (GCF) HIF-1alpha, VEGF, and TNF-alpha levels in generalized ag
128 n displayed significantly increased gingival HIF-1alpha protein levels and bone regeneration, as comp
129  are mediated mainly by two isoforms of HIF, HIF-1alpha and HIF-2alpha.
130 nhibit the CRL2(VHL) complex leading to high HIF-1alpha protein levels and a metabolic shift to glyco
131 d a preserved ERK1/2 phosphorylation, higher HIF-1alpha and Glut1 levels, and substantially increased
132 g in Enz resistance via altering the hypoxia HIF-1alpha signals.
133                                      Hypoxia/HIF-1alpha- and extracellular adenosine/A2 adenosine rec
134 motivated by the need to prevent the hypoxia/HIF-1alpha-driven accumulation of extracellular adenosin
135 using human ccRCC cell lines have implicated HIF-1alpha as an inhibitor and HIF-2alpha as a promoter
136 dative stress in MeHg-induced alterations in HIF-1alpha levels.
137 idants, reversed the MeHg-induced decline in HIF-1alpha protein levels and the decrease in cell proli
138 icantly blocked the MeHg-induced decrease in HIF-1alpha expression (p < 0.05).
139                              The decrease in HIF-1alpha modulated a couple key angiogenic and anti-an
140  in the absence of a significant decrease in HIF-1alpha mRNA levels.
141 ation of UBXN7, with concomitant increase in HIF-1alpha protein levels, reduction in oxidative phosph
142 L-4-dependent, hypoxia-mediated increases in HIF-1alpha and T(C)2 cell differentiation were shown to
143 ated virus that expressed Cre-recombinase in HIF-1alpha floxed mice.
144      MeHg induced a significant reduction in HIF-1alpha protein by activating proline hydroxylase (PH
145 2alpha were determined, as were responses in HIF-1alpha-deficient OT-1 cells.
146 , HIF-1alpha protein levels were restored in HIF-1alpha stabilizer-treated senescent endothelial cell
147 binds, deacetylates, and thereby inactivates HIF-1alpha.
148                          Thus, inappropriate HIF-1alpha signalling results in skeletal dysplasia caus
149 l as several transcription factors including HIF-1alpha.
150 tein response and autophagy genes, including HIF-1alpha, NFkB, PERK, and SQSTM1/p62.
151 itin ligase that targets proteins, including HIF-1alpha, for proteasomal degradation.
152 ties were decreased accompanied by increased HIF-1alpha and erythropoietin levels in the kidneys of K
153 villous explants demonstrated that increased HIF-1alpha resulting from ADORA2B activation facilitates
154 se control in people with diabetes increases HIF-1alpha protein and has wide-ranging benefits, some o
155                                 IH increases HIF-1alpha and decreases HIF-2alpha protein levels.
156 t effects of different methods of increasing HIF-1alpha, even within the same tissues.
157 played a neuroprotective role via increasing HIF-1alpha expression in response to MeHg toxicity.
158 xia inducible transcription factor isoforms, HIF-1alpha and HIF-2alpha, and pulmonary hypoxia to inve
159  gene activation include c-MYC, KRAS, c-KIT, HIF-1alpha, PDGF-A and hTERT.
160                                    Likewise, HIF-1alpha failed to activate transcription from Zp when
161 o the mammary fat pads of syngeneic LysMcre, HIF-1alpha (fl/fl) /LysMcre, or HIF-2alpha (fl/fl) /LysM
162                                   Macrophage HIF-1alpha-deficient tumors also responded significantly
163  numbers of proangiogenic TEMs in macrophage HIF-1alpha-deficient tumors presented significantly less
164                               Redox-mediated HIF-1alpha inactivation also decreased the expression of
165 ult in the suppression of succinate-mediated HIF-1alpha activation, imposing a consequent reduction o
166                    In normoxic control mice, HIF-1alpha deletion in the CNS or NTS did not affect ven
167                          In primary neurons, HIF-1alpha was stabilised by FG4592 (30 uM) and DMOG (10
168                                     Of note, HIF-1alpha protein levels were restored in HIF-1alpha st
169 lpha(-/-) and significantly decreased in NTS-HIF-1alpha(-/-) compared to control mice (P < 0.0001).
170 cence showed that HIF-1alpha deletion in NTS-HIF-1alpha(-/-) was restricted to glutamatergic neurons.
171 as deleted in NTS neurons in adult mice (NTS-HIF-1alpha(-/-) ) by microinjecting adeno-associated vir
172                               The absence of HIF-1alpha impaired the survival and proliferation of pr
173                         Since the absence of HIF-1alpha is detrimental to host control of infection,
174 ected mice inhibited nuclear accumulation of HIF-1alpha and HIF-2alpha protein in immune cell types a
175 orter assay despite inducing accumulation of HIF-1alpha and transcription from another HRE-containing
176                      Increased activation of HIF-1alpha in ATM of obese visceral adipose tissue resul
177 ll development because genetic activation of HIF-1alpha in murine B cells led to reduced repertoire d
178 e Western Blot data showed the activation of HIF-1alpha, but not Notch, ERK1/2, (PI3K)AKT, and P38 pa
179              Thus, therapeutic activation of HIF-1alpha-dependent vascular repair may represent a nov
180 l of infection, we asked if large amounts of HIF-1alpha protein, exceeding those induced by H. capsul
181 d suggest that alterations in the balance of HIF-1alpha and HIF-2alpha activities can affect differen
182 cies and demonstrated therapeutic benefit of HIF-1alpha-stabilizing drugs.
183              This p53-induced chaperoning of HIF-1alpha increases synthesis of HIF-regulated genes an
184 ive cell lines are reactivated by classes of HIF-1alpha-stabilizing drugs.
185 KDM8/PKM2 complex serves as a coactivator of HIF-1alpha to upregulate glycolytic genes.
186 that reduced SIRT1-mediated deacetylation of HIF-1alpha contributes to the elevated levels of aromata
187                       Compound deficiency of HIF-1alpha and HIF-2alpha led to humoral defects after h
188 omotes the ubiquitination and degradation of HIF-1alpha.
189                     Constitutive deletion of HIF-1alpha in CNS neurons in transgenic mice tended to b
190                      Conditional deletion of HIF-1alpha in glutamatergic neurons of the nucleus tract
191 h pulmonary endothelium-specific deletion of HIF-1alpha or HIF-2alpha, to characterise their roles in
192 ith macrophage-specific targeted deletion of HIF-1alpha, we demonstrate the critical role of HIF-1alp
193 S1P specifically binds to the PAS domains of HIF-1alpha.
194 the present study, we analyzed the effect of HIF-1alpha in human macrophages infected with this fungu
195 le of this activation, we tested efficacy of HIF-1alpha inhibitor echinomycin in TP53-mutated AML sam
196 V life cycle by regulating the expression of HIF-1alpha and HIF-2alpha proteins.IMPORTANCE Hypoxia in
197 cine and CoCl(2) increased the expression of HIF-1alpha and target genes, including angiogenic and ce
198 -A expression, we analyzed the expression of HIF-1alpha during infection.
199 ime PCR was used to detect the expression of HIF-1alpha mRNA.
200 rial respiration and occurs independently of HIF-1alpha.
201                Here we describe induction of HIF-1alpha and HIF-2alpha during the differentiation of
202                  Pharmacologic inhibition of HIF-1alpha or genetic manipulation to reduce HIF-1alpha
203 ell proliferation, whereas the inhibition of HIF-1alpha significantly increased the decline in cell p
204 s regulated by EPAS1 (HIF-2alpha) instead of HIF-1alpha, and also that propranolol-induced apoptosis
205                                 Knockdown of HIF-1alpha did not affect osteoclast differentiation but
206                                 Knockdown of HIF-1alpha expression via short interference RNA decreas
207 ng hypoxia increased the expression level of HIF-1alpha compared to static hypoxia.
208 hort interference RNA decreased the level of HIF-1alpha expression in MEK2-deficient BMDMs and decrea
209  mice was paralleled by increased numbers of HIF-1alpha+ monocytes, suggesting that CMH enhances mono
210                            Overexpression of HIF-1alpha significantly attenuated the decline in MeHg-
211     Hence, the pharmacological prevention of HIF-1alpha degradation by prolyl hydroxylase (PHD) under
212 y CHX, MeHg promoted the degradation rate of HIF-1alpha.
213 ved the islets survival through reduction of HIF-1alpha and ROS production and suppression of apoptos
214 betes or its complications via regulation of HIF-1alpha have not currently proven to be clinically us
215 work demonstrates that dynamic regulation of HIF-1alpha is essential for normal B cell development.
216  and IL-17 since targeted down regulation of HIF-1alpha via short interfering RNA or a HIF-1alpha inh
217  the nucleus are linked to the regulation of HIF-1alpha/2alpha functions associated with breast cance
218 impaired claudin-1 barrier via repression of HIF-1alpha/claudin-1 signaling, which was restored by tr
219 er there is a requirement for restriction of HIF-1alpha signalling in the other regions of the growth
220  approaches confirmed the regulatory role of HIF-1alpha in BACE1-AS/BACE1 in Tat-mediated amyloidosis
221    These studies reveal an oncogenic role of HIF-1alpha in ccRCC initiation and suggest that alterati
222                   To investigate the role of HIF-1alpha in MeHg-induced neurotoxicity, cobalt chlorid
223 aim of this study was to explore the role of HIF-1alpha in response to acute MeHg exposure in rat bra
224 -1alpha, we demonstrate the critical role of HIF-1alpha-derived from macrophages in regulating ATM ac
225 )) mice, which displayed higher stability of HIF-1alpha.
226 duced early, but not later, stabilization of HIF-1alpha.
227                  By examining the 5' UTRs of HIF-1alpha, FGF-9, and p53 mRNAs and using fluorescence
228  decreased, indicating a broad dependence on HIF-1alpha for development of the sympathetic nervous sy
229                 Abrogation of either STC1 or HIF-1alpha alleviated HSPC suppression by AML.
230 f phosphatase and tensin homolog (PTEN) over HIF-1alpha expression and CSC accumulation are de-regula
231 intramuscular delivery of CSC overexpressing HIF-1alpha (HIF-CSC) significantly improved the blood fl
232 geting this newly identified TR4/lincRNA-p21/HIF-1alpha/VEGF-A signaling with Bex, an FDA-approved dr
233 nsitivity via modulating the TR4/lincRNA-p21/HIF-1alpha/VEGF-A signaling.
234 1 axis, which was restored via pharmacologic HIF-1alpha stabilization ex vivo.
235  and triple mutation on ERK phosphorylation, HIF-1alpha expression, and IL-1beta production.
236 2 (pyruvate kinase M2), phosphorylated PKM2, HIF-1alpha (hypoxia-inducible factor-1alpha), and lactat
237  we demonstrated that (a) elevated placental HIF-1alpha by AT(1) -AA or LIGHT upregulates CD73 and AD
238 nced adenosine underlies increased placental HIF-1alpha in an angiotensin receptor type 1 receptor ag
239 hrough upregulated ADORA2B induces placental HIF-1alpha expression, which creates a positive feedback
240                       Knockdown of placental HIF-1alpha in vivo suppressed the accumulation of adenos
241 at placental hypoxia induces ROS production, HIF-1alpha stabilization, and sFLT1 up-regulation; these
242                  Here we show that prolonged HIF-1alpha signalling in chondrocytes leads to skeletal
243                     We conclude that RASSF1A-HIF-1alpha forms a feedforward loop driving hypoxia sign
244 (2)S produced by the infected WT mice reduce HIF-1alpha levels, thereby suppressing glycolysis and pr
245 HIF-1alpha or genetic manipulation to reduce HIF-1alpha expression reduced the hypoxia-enhanced diffe
246 ide donor, prevented ROS production, reduced HIF-1alpha protein levels, and diminished sFLT1 producti
247           CRL2(VHL) ligase complex regulates HIF-1alpha protein levels under aerobic (normoxia) or an
248 se, which inversely proportionally regulates HIF-1alpha and IL-1beta expression independent of ERK ac
249 ry role in the KSHV life cycle by regulating HIF-1alpha and HIF-2alpha expression.
250 n 1 (STC1) and its transcriptional regulator HIF-1alpha as limiting factors for HSPC proliferation.
251 tient biopsy analysis identified a repressed HIF-1alpha/claudin-1 axis, which was restored via pharma
252           Collectively, these studies reveal HIF-1alpha's critical role in maintaining barrier and hi
253                                     Salivary HIF-1alpha concentrations in gingivitis group were signi
254 gingival crevicular fluid (GCF) and salivary HIF-1alpha, VEGF, and TNF-alpha levels in periodontal he
255                                      Second, HIF-1alpha was deleted in NTS neurons in adult mice (NTS
256 n levels were reduced uniformly by selective HIF-1alpha inhibitor CAY10585.
257                              Here, we showed HIF-1alpha target genes are enriched in TP53-mutated ver
258            These findings indicate that some HIF-1alpha-stabilizing drugs may be helpful as part of a
259  In conclusion, the PHD inhibitors stabilise HIF-1alpha in normoxia, induce autophagy, and protect ce
260  at 100 uM except for DMOG, which stabilised HIF-1alpha at 1 and 2 mM.
261 enesis, despite their inability to stabilize HIF-1alpha.
262 of esophageal epithelial-targeted stabilized HIF-1alpha.
263  kinase M2), phosphorylated PKM2, succinate, HIF-1alpha (hypoxia-inducible factor-1alpha), lactate, a
264                                  In summary, HIF-1alpha and HIF-2alpha play different but overlapping
265 nt of human neutrophils with IL-4 suppressed HIF-1alpha-dependent hypoxic survival and limited proinf
266 mental hypoxia or HIF1A knockdown suppressed HIF-1alpha-dependent claudin-1 expression and epithelial
267                               By suppressing HIF-1alpha and other oncogenic transcription factors, Ti
268 he ability of the protein to bind its target HIF-1alpha.
269 ors (MSTFs) (KLF2, KLF4, NRF2, YAP/TAZ/TEAD, HIF-1alpha, NF-kappaB, AP-1, and others).
270 croenvironment within keloid tumors and that HIF-1alpha blockade could be a novel avenue of treatment
271              Therefore, we hypothesized that HIF-1alpha promotes the high muscle healing capacity of
272                    The results indicate that HIF-1alpha is a necessary signal for VAH and the previou
273                     These data indicate that HIF-1alpha is a target of miRNA-126 in protective and re
274                        We also observed that HIF-1alpha activated the expression of paired box (Pax)7
275 criptomic and proteomic analyses reveal that HIF-1alpha regulates glycolysis while HIF-2alpha regulat
276 lysis of transductional events revealed that HIF-1alpha upregulated Kdm5b and Kdm6b expression, where
277         Using a hypoxia-tracer, we show that HIF-1alpha nuclear translocation occurred both in hypoxi
278                    We previously showed that HIF-1alpha binds the BZLF1 gene promoter, inducing Zta s
279               Immunofluorescence showed that HIF-1alpha deletion in NTS-HIF-1alpha(-/-) was restricte
280 so extended previous studies by showing that HIF-1alpha in retinal neurons and HIF-2alpha in Muller g
281                 We found, unexpectedly, that HIF-1alpha-stabilizing drugs only induce reactivation wh
282                             We verified that HIF-1alpha protein is more strongly expressed in keloid
283 rosis by upregulating HE4 and activating the HIF-1alpha/HE4/NF-kappaB signaling pathway.
284 he expression of glycolytic enzymes, and the HIF-1alpha inhibitor (FIH) inhibits HIF-1 activity.
285 ole in maintaining barrier and highlight the HIF-1alpha/claudin-1 axis as a potential therapeutic tar
286 omas (ccRCC), leading to accumulation of the HIF-1alpha and HIF-2alpha transcription factors.
287 the first report implicating the role of the HIF-1alpha/lncRNABACE1-AS/BACE1 axis in Tat-mediated ind
288 and ITGA5, causes further suppression of the HIF-1alpha/LOX/ITGA5/FN1 axis.
289                       In hypoxic cells, this HIF-1alpha-induced p53 is transcriptionally inefficient
290 tor of VEGFR-Notch signaling circuit through HIF-1alpha and RBPJkappa in EC sprouting angiogenesis.
291 hyperresponsiveness and inflammation through HIF-1alpha activation.
292                                       Unlike HIF-1alpha, dose-dependent coexpression of ORF34 stabili
293 on (ChIP) was performed in Caco-2 IECs using HIF-1alpha- or HIF-2alpha-specific antibodies.
294    Here we demonstrate a novel pathway where HIF-1alpha transcriptionally upregulates both WT and MT
295 etected in corneal epithelial cells, whereas HIF-1alpha protein stabilization was observed in infiltr
296                              Moreover, while HIF-1alpha inhibition reduced tube formation and wound h
297       We have shown SphK2 is associated with HIF-1alpha in protein complexes, and is enriched at the
298 parsely and without spatial association with HIF-1alpha, arguing for an importance of hypoxia-indepen
299 ylated, wild-type p53 as a coactivator, with HIF-1alpha binding recruiting p53 to Zp.IMPORTANCE EBV,
300 rs and Burkitt lymphomas were incubated with HIF-1alpha-stabilizing drugs: the iron chelator deferoxa

 
Page Top